Filterable spreadsheets of vaccine effectiveness studies included in the weekly summary tables. Separate spreadsheets are available for primary series and booster dose studies.

This table summarizes the vaccine effectiveness data for COVID-19 studies conducted globally. This table is updated weekly. 

The Vaccine Economics Research for Sustainability and Equity (VERSE) project evaluated the status of vaccine coverage and equity status in Uganda in 2016.

These forest plots summarize available COVID-19 vaccine effectiveness against Omicron variant by vaccine and population of special interest, and for second booster dose and duration of effectiveness. These forest plots are updated weekly.

This plot summarizes the available laboratory evidence on the ability of COVID-19 vaccines to neutralize SARS-CoV-2 variants of concern.

This document summarizes COVID-19 vaccine safety published studies and survey results in map form. Full results can be found on the VIEW-hub COVID safety module.

The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the

In partnership with the Asian Development Bank, IVAC summarized the evidence for COVID-19 vaccine performance against Omicron sub-variants.

This document provides an overview of the available laboratory evidence on the ability of the bivalent Omicron-containing mRNA COVID-19 vaccines to neutralize Omicron subvariants.

These forest plots summarize the available evidence on the vaccine effectiveness of the bivalent Omicron-containing mRNA COVID-19 vaccines.